Literature DB >> 514083

Differential sensitivity to somatostatin of pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas.

K Hermansen, T W Schwartz.   

Abstract

This dose-response study deals with the relative inhibitory effect of somatostatin on the acetylcholine-stimulated release of pancreatic polypeptide (PP), glucagon, and insulin from the isolated canine pancrease. Somatostatin in picomolar doses potently inhibited insulin and glucagon secretion, whereas PP secretion was relatively insensitive. Also, in the absence of acetylcholine, somatostatin exerted a preferential inhibition of the release insulin and glucagon compared with PP. These findings point to a physiologically important role of somatostatin for the secretion of insulin and glucagon, but probably not for PP.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 514083     DOI: 10.1016/0026-0495(79)90135-5

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  4 in total

1.  Involvement of alpha1 and beta-adrenoceptors in adrenaline stimulation of the glucagon-secreting mouse alpha-cell.

Authors:  Elaine Vieira; Yi-Jia Liu; Erik Gylfe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-01-15       Impact factor: 3.000

Review 2.  Secretion of somatostatin from the normal and diabetic pancreas. Studies in vitro.

Authors:  K Hermansen
Journal:  Diabetologia       Date:  1980       Impact factor: 10.122

3.  Haloperidol, and insulin and glucagon secretion.

Authors:  K Hermansen
Journal:  Diabetologia       Date:  1980-07       Impact factor: 10.122

4.  The influence of somatostatin on glucagon and pancreatic polypeptide secretion in the isolated perfused human pancreas.

Authors:  R Kleinman; R Gingerich; G Ohning; H Wong; K Olthoff; J Walsh; F C Brunicardi
Journal:  Int J Pancreatol       Date:  1995-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.